Table 2 Reasons for switching to EHL (n = 20).
Primary reasons | n (%) |
|---|---|
Better efficacy | 7 (35.0) |
Improved efficacy expected | 2 (10.0) |
High number of bleeds with SHL | 5 (25.0) |
Prolonged half-life | 4 (20.0) |
Extended half-life | 2 (10.0) |
Reduced prophylactic infusion frequency | 2 (10.0) |
Convenience/patient preference | 4 (20.0) |
Patient preference | 2 (10.0) |
Difficult venous access | 2 (10.0) |
Other | 5 (25.0) |
Previous SHL no longer available | 2 (10.0) |
Study participation | 2 (10.0) |
Inhibitors | 1 (5.0) |
Secondary reasons | n (%) |
No secondary reason given | 12 (60.0) |
Extended half-life | 2 (10.0) |
Reduced prophylactic infusion frequency | 2 (10.0) |
Efficacy | 1 (5.0) |
Pain | 1 (5.0) |
Difficult venous access | 1 (5.0) |
Depression | 1 (5.0) |
